It appears that the Boston Red Sox had dodged a bullet.

Pitching ace Chris Sale will not need to undergo Tommy John surgery however it appears the veteran lefty will be out for the remainder of the 2019 regular season. It is also unlikely that he will be available for the postseason if Boston can earn a playoff spot.

Sale took a trip to Florida on Monday to visit Dr. James Andrews, with him confirming the pitcher’s previous diagnosis of elbow inflammation.

He received a platelet-rich plasma shot in his elbow, and Andrews recommended that he be re-evaluated in six weeks.

The Red Sox places Sale on the 10-day injured list on Saturday after he felt stiffness in his elbow following a start last week.

This season has not been too kind to the 30-year old as it has been the worst of his career. He is sporting a 6-11 record with an ERA of 4.40 through 147 and a third innings, but he still leads major league starters with 13.3 strikeouts per nine innings.

The seven-time All-Star was signed by the Red Sox to a five-year, $145 million contract extension back in March. The deal runs through the 2024 campaign.